Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Touched its 52-Week Low on Nov 22, 2016


Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) has a 1 Year Target Estimate of $3. The stock traded with the volume of 2.7 Million in the last trading session. Interpace Diagnostics Group, Inc. opened at $0.27 and closed by showing a decrease of -42%. The Bid price in the last session was $0.15 x 2900 and the Ask price was $0.17 x 3200. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Interpace Diagnostics Group, Inc. has the Market Capitalization of 3.2 Million. The Stock has its 52-week High of $0.77 and 52-Week Low of $0.07 and it touched its 52-week high on Dec 2, 2015 and 52-Week Low on Nov 22, 2016.

Interpace Diagnostics Group, Inc. reported its last Earnings on Nov 15 AMC where the company reported Actual EPS of $-0.25/Share whereas, the Analyst Estimated EPS was $-0.4/share. The difference between Actual EPS and Estimated EPS was $0.15/share. This represented an Earnings Surprise of 37.5%.

1 number of analysts also provided their insight on Interpace Diagnostics Group, Inc., where the Average Price Target for the stock is $3. They also projected Low Price Target as $3 while High Price Target is set at $3.

A number of analysts rated the stock as well: 0 analysts believe that the stock is a STRONG BUY while 0 reported it as Buy.0 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Interpace Diagnostics Group, Inc. annual Divided is 0 while it’s Dividend Yield is 0%. The stock has its Price to Earnings (P/E) ratio of 0 and Forward Price to Earnings ratio of 0. The company has its Price to Sales (P/S) ratio of 0.28 where Price to Book (P/B) ratio of 0, Price to Cash Per share (P/C) of 1.91 and Price to Free Cash Flow (P/FCF) has a value of 0.

The company has its Return on Assets (ROA) of 0 Percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) displays a value of -127.4%.

The stock is currently trading at Distance from 20-Day simple moving Average of 35.48% whereas, Distance from 50-Day Simple moving average is 19.2 Percent and Distance from 200-Day Simple Moving Average of -36.46 percent.

A look at performance overview of Interpace Diagnostics Group, Inc. depicts that Performance (Week) is 120.25 percent while Performance Month is 35.54%. Quarterly performance shows a value of -32.23% and Half Year Performance value stands at -48.18%. Yearly performance of the stock has the value of -77.7 percent. Interpace Diagnostics Group, Inc. has its YTD performance of -62.51 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 2 Feb 2016 where Chief Executive Officer Stover (Jack E) did a transaction type “Buy” in which 100000 shares were traded at a price of $0.53. Another insider trade includes Director Glorikian (Harry) who also initiated a transaction in which 127696 shares were traded on 2 Feb 2016 as “Buy”. On 2 Feb 2016 Director Keegan (Joseph D) traded 127696 shares as “Buy” at $0.47. Chief Financial Officer Miao (Graham G) Sell 69020 shares on 27 Dec 2015 at the price of $0.53.